Balloon dilation procedure for treating Eustachian tube dysfunction
Official title: Efficacy of Balloon Dilation of the Eustachian Tube in Eustachian Tube Dilatory Dysfunction: a Randomized, Sham-controlled Trial
Run by University of Calgary · NCT05719207 · Data updated 2026-11-12
This study is testing if a balloon dilation procedure can help people with Eustachian tube dysfunction feel better compared to a fake treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 76 (estimated) |
| Sponsor | University of Calgary Academic / other |
| Drugs / interventions | radiation |
| Locations | 2 sites (Calgary, Alberta and 1 other locations) |
| Status | Recruiting |
| Started | June 25, 2023 |
| Main results expected | December 1, 2025 |
| Study ends | December 1, 2025 |
| Registry record updated | April 3, 2025 |
| Trial ID | NCT05719207 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults with chronic ETDD or baro-challenge ETDD who have not responded to conservative treatments.
✕Probably not a fit
Patients with patulous eustachian tube dysfunction or those who do not meet the inclusion criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of balloon dilation of the eustachian tube in patients suffering from eustachian tube dilatory dysfunction (ETDD). Participants will be randomly assigned to receive either the balloon dilation procedure or a sham procedure to assess the treatment's superiority. The study aims to identify patient characteristics that correlate with positive outcomes and to confirm the safety of the balloon dilation technique. This research addresses a significant gap in effective treatments for ETDD, which currently lacks reliable medical options.
Why it matters
Potential benefit: If successful, this procedure could provide a new, effective treatment option for patients suffering from Eustachian tube dysfunction.
How similar studies have gone: Previous studies have shown promising results for balloon dilation of the eustachian tube, but this study aims to provide more rigorous evidence through a placebo-controlled design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (Chronic ETDD): * \>3 months of symptoms of ETDD (otalgia, ear pressure, muffled hearing, tinnitus, cracking or popping, feeling clogged) persistent at enrollment * Persistence of symptoms despite \>4 weeks INCS or \>7d course of systemic steroid within 6 months from enrollment * Documented Type B or C tympanogram at or within 6 months from enrollment * ETDQ7 ≥ 2.1 at enrollment Inclusion criteria (baro-challenge ETDD): * \>12 months of baro-challenge induced symptoms occurring at least every 4 months within the past year * Symptoms include otalgia, ear pressure, muffled hearing, tinnitus, cracking or popping, feeling clogged, vertigo, or facial nerve palsy, which resolve within 3 days of pressure equalization. * Failure of at least one of: topical/oral decongestant, pneumatization device, and/or pressure relief ear plugs. Exclusion Criteria: * Signs/symptoms of patulous eustachian tube dysfunction (autophony, tympanic membrane movement with breathing) * Adjunctive surgical procedure needed (ex. septoplasty, tympanostomy tube) * Presence of a tympanic membrane (TM) perforation or tympanostomy tube * Fluctuating SNHL, AOM, grade IV TM retraction, or tympanosclerosis of \>50% of the TM * Uncontrolled sino-nasal disease, reflux, TMJ disorder, immunodeficiency, or allergies * Known ICA dehiscence of the bony ET of the symptomatic ear * Recent head and neck surgery within the past 3 months or planned procedure during study * History of radiation to the head and neck * History of craniofacial abnormality * Prior ET intervention * Psychiatric condition or cognitive impairment which precludes capacity to consent.
Where it's running
-
Otology Clinic, Clinic 7A, South Health Campus
Calgary, Alberta, Canada Recruiting -
Sunnybrook Health Sciences Center
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Justin Lui, MD, FRCSC — University of Calgary
- Study coordinator: Jaimi Workun
- Email: jaimi.workun@albertahealthservices.ca
- Phone: 403-764-4755
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nasal Dilator Therapy for Patulous Eustachian Tube
This study tests whether wearing a nasal dilator helps reduce symptoms in adults with patulous Eustachian tube dysfunction.
-
Buteyko breathing plus smoking-hygiene for adolescents with passive household smoke exposure and chronic Eustachian tube dysfunction
This project will test whether adding regular Buteyko breathing exercises to smoking-hygiene education helps adolescents exposed to household tobacco smoke who have chronic Eustachian tube dysfunction and reduced lung function.
-
Buteyko breathing for seniors with chronic obstructive Eustachian tube dysfunction
This trial will try adding daily Buteyko breathing exercises to usual care to see if it helps seniors with chronic Eustachian tube dysfunction.
-
New nasal spray delivery system for treating Eustachian tube dysfunction
This study tests a new nasal spray to see if it can help people with Eustachian tube dysfunction feel better by delivering medication more effectively.
-
Evaluating balloon sinuplasty for maxillary sinusitis
This study is testing if balloon sinuplasty can help people with chronic or recurrent maxillary sinusitis feel better compared to a fake surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.